Rabies immune globulin purified - GrifolsAlternative Names: RIG-C
Latest Information Update: 17 Sep 2014
At a glance
- Originator Grifols
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Rabies
Most Recent Events
- 01 May 2014 Grifols completes a phase I trial in Rabies (Prevention) in USA (NCT02139657)
- 01 Mar 2014 Phase-I clinical trials in Rabies (Prevention) in USA (IM) (NCT02139657)